Company NPS Pharmaceuticals, Inc.
Equities
US62936P1030
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
2015 | NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval | RE |
2015 | NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 108,581,155 | 108,074,845 ( 99.53 %) | 0 | 99.53 % |
Company contact information
![address NPS Pharmaceuticals, Inc.](https://cdn.zonebourse.com/static/address/10233.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- Stock
- Company NPS Pharmaceuticals, Inc.